WST

WST Retained Earnings

$4.62BQuarterly · USD

Period ending:

WST FY Retained EarningsUSD
WST FY Retained Earnings1985-12-31: $113.40M1986-12-31: $126.50M1987-12-31: $134.70M1988-12-31: $148.50M1989-12-31: $162.60M1990-12-31: $160.60M1991-12-31: $139.70M1992-12-31: $153.10M1993-12-31: $169.90M1994-12-31: $189.80M1995-12-31: $210.20M1996-12-31: $217.70M1997-12-31: $252.50M1998-12-31: $249.30M1999-12-31: $278.10M2000-12-31: $269.80M2001-12-31: $254.00M2002-12-31: $261.20M2003-12-31: $281.20M2004-12-31: $287.50M2005-12-31: $318.60M2006-12-31: $375.70M2007-12-31: $450.30M2008-12-31: $517.30M2009-12-31: $569.40M2010-12-31: $612.60M2011-12-31: $664.50M2012-12-31: $719.90M2013-12-31: $805.00M2014-12-31: $902.20M2015-12-31: $964.60M2016-12-31: $1.07B2017-12-31: $1.18B2018-12-31: $1.35B2019-12-31: $1.55B2020-12-31: $1.85B2021-12-31: $2.46B2022-12-31: $2.99B2023-12-31: $3.52B2024-12-31: $3.96B2025-12-31: $4.37B$4.37B$0.00
1985-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

WST retained earnings history

Cumulative earnings retained in the business. The available annual fiscal periods series contains 41 observations from Dec 31, 1985 to Dec 31, 2025.

West Pharmaceutical Services Retained Earnings — Annual fiscal periods (USD)
Period endingRetained Earnings (USD)
4,374,900,000
3,956,600,000
3,523,400,000
2,987,800,000
2,456,700,000
1,846,700,000
1,549,400,000
1,353,400,000
1,178,200,000
1,071,600,000
964,600,000
902,200,000
805,000,000
719,900,000
664,500,000
612,600,000
569,400,000
517,300,000
450,300,000
375,700,000
318,600,000
287,500,000
281,200,000
261,200,000
254,000,000
269,800,000
278,100,000
249,300,000
252,500,000
217,700,000
210,200,000
189,800,000
169,900,000
153,100,000
139,700,000
160,600,000
162,600,000
148,500,000
134,700,000
126,500,000
113,400,000

Compare retained earnings

All WST financial metrics · WST stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.